TUMOR NECROSIS FACTOR-α INHIBITORS IN THE TREATMENT OF AXIAL SPONDYLOARTHRITIS, INCLUDING ANKYLOSING SPONDYLITIS

TUMOR NECROSIS FACTOR-α INHIBITORS IN THE TREATMENT OF AXIAL SPONDYLOARTHRITIS, INCLUDING ANKYLOSING SPONDYLITIS

The paper provides guidelines for the use of tumor necrosis factor-α  (TNF-α) inhibitors in the treatment of patients with axial spondyloarthritis  (axSpA), including ankylosing spondylitis. It gives data on the efficacy of TNF-α inhibitors in patients with non-radiographic axSpA. By using internati...

Full description

Bibliographic Details
Main Authors: S. A. Lapshina, T. V. Dubinina, V. V. Badokin, A. G. Bochkova, O. V. Bugrova, I. Z. Gaidukova, A. A. Godzenko, A. A. Dubikov, O. N. Ivanova, T. V. Korotaeva, O. B. Nesmeyanova, I. P. Nikishina, E. N. Otteva, T. A. Raskina, A. P. Rebrov, O. A. Rumyantseva, A. V. Sitalo, A. V. Smirnov, Sh. F. Erdes
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2016-09-01
Series:Научно-практическая ревматология
Subjects:
axial spondyloarthritis
ankylosing spondylitis
tumor necrosis factor-α (tnf-α) inhibitors
efficacy
safety
Online Access:https://rsp.mediar-press.net/rsp/article/view/2257

Internet

https://rsp.mediar-press.net/rsp/article/view/2257

Similar Items